Bio­phar­ma lead­ers con­demn mob vi­o­lence on Capi­tol Hill, look­ing to close Trump's chaot­ic chap­ter in Amer­i­can his­to­ry

Some of the lead­ing voic­es in bio­phar­ma have had a dif­fi­cult time over the last 4 years watch­ing Don­ald Trump march through Amer­i­can his­to­ry with an of­ten frac­tious view of the drug in­dus­try. Bio­phar­ma lead­ers and or­ga­ni­za­tions have con­demned the ad­min­is­tra­tion’s im­mi­gra­tion poli­cies and ve­he­ment­ly ob­ject­ed to Trump’s drug pric­ing pro­pos­als. But they al­so en­joyed the warm em­brace of Trump’s Op­er­a­tion Warp Speed in a sprint to de­vel­op new vac­cines and drugs for Covid-19, with heavy gov­ern­ment sub­si­dies, even if the pres­i­dent al­so ac­cused Pfiz­er of drag­ging its feet on their ap­pli­ca­tion for an OK to get clear of vot­ing day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER